9th Annual Biomarkers Congress

Oncology: Bayer AG

Total Score People Score Events Score
8 6 8
Date Event Presentation Speakers
June 9, 2009 Cell and Tissue-Based Assays for HTS Developing High Quality Assays for Screening 2.5 Million Compounds Elisabeth Pook
January 26, 2009 Circulating HER-2/neu, A Biomarker for HER-2 Positive Breast Cancer, from Discovery to Patient Management Walter P. Carney
January 26, 2009 Biomarker Assay Development Circulating HER-2/neu, A Biomarker for HER-2 Positive Breast Cancer, from Discovery to Patient Management Walter P. Carney
January 5, 2009 High Content Analysis Effective Support of Oncology Driven Drug Research by Functional High-Content Analysis Stefan Prechtl
November 17, 2008 BIO-Europe 2008 Rethinking R&D: Can Big Pharma Address the Productivity Gap through Earlier-Stage Collaborations? Michael A. Yeomans
May 4, 2008 Impact China IV: Pharmaceutical R&D Global Summit Conducting Clinical Trials in China Min Irwin
March 25, 2008 Clinical Trials Asia Optimizing Return on Investment (ROI) of Multinational and Min Irwin
November 5, 2007 Second Annual Biomarkers Europe Nov (05-06) BIOMARKERS FOR EARLY CLINICAL TRIALS (08:00-12:15) Georg Wensing
BIOMARKERS FOR EARLY CLINICAL TRIALS: The Application of Biomarkers in Early (Phase I) Clinical Development (11:00-11:30) Georg Wensing
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.